Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Critical Care (London, England)
|
January 20, 2006
Study protocol: The Improving Care of Acute Lung Injury Patients (ICAP) study
Dale M Needham, Cheryl R Dennison, David W Dowdy, et al.
BMJ (Clinical Research Ed.)
|
April 12, 2012
Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study
Dale M Needham, Elizabeth Colantuoni, Pedro A Mendez-Tellez, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 11, 2014
Risk factors for physical impairment after acute lung injury in a national, multicenter study
Dale M Needham, Amy W Wozniak, Catherine L Hough, et al.
American Journal of Hematology
|
July 26, 2019
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
Ali Bukhari, Firas El Chaer, Rima Koka, et al.
Thorax
|
September 18, 2017
Return to work and lost earnings after acute respiratory distress syndrome: a 5-year prospective, longitudinal study of long-term survivors
Biren B Kamdar, Kristin A Sepulveda, Alexandra Chong, et al.
Thorax
|
January 22, 2017
Are physical measures related to patient-centred outcomes in ARDS survivors?
Kitty S Chan, Lisa Aronson Friedman, Victor D Dinglas, et al.
Critical Care Medicine
|
November 20, 2013
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study
Eddy Fan, David W Dowdy, Elizabeth Colantuoni, et al.
The New England Journal of Medicine
|
May 20, 2014
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
, Jonathon D Truwit, Gordon R Bernard, et al.
Phlebology
|
September 16, 2022
Clinical outcomes and echocardiographic characteristics between African American and Caucasian patients with acute pulmonary embolism
Rafael S Cires-Drouet, Jacob Sama, Paul Han, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Critical Care (London, England)
|
January 20, 2006
Study protocol: The Improving Care of Acute Lung Injury Patients (ICAP) study
Dale M Needham, Cheryl R Dennison, David W Dowdy, et al.
BMJ (Clinical Research Ed.)
|
April 12, 2012
Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study
Dale M Needham, Elizabeth Colantuoni, Pedro A Mendez-Tellez, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 11, 2014
Risk factors for physical impairment after acute lung injury in a national, multicenter study
Dale M Needham, Amy W Wozniak, Catherine L Hough, et al.
American Journal of Hematology
|
July 26, 2019
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
Ali Bukhari, Firas El Chaer, Rima Koka, et al.
Thorax
|
September 18, 2017
Return to work and lost earnings after acute respiratory distress syndrome: a 5-year prospective, longitudinal study of long-term survivors
Biren B Kamdar, Kristin A Sepulveda, Alexandra Chong, et al.
Thorax
|
January 22, 2017
Are physical measures related to patient-centred outcomes in ARDS survivors?
Kitty S Chan, Lisa Aronson Friedman, Victor D Dinglas, et al.
Critical Care Medicine
|
November 20, 2013
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study
Eddy Fan, David W Dowdy, Elizabeth Colantuoni, et al.
The New England Journal of Medicine
|
May 20, 2014
Rosuvastatin for sepsis-associated acute respiratory distress syndrome
, Jonathon D Truwit, Gordon R Bernard, et al.
Phlebology
|
September 16, 2022
Clinical outcomes and echocardiographic characteristics between African American and Caucasian patients with acute pulmonary embolism
Rafael S Cires-Drouet, Jacob Sama, Paul Han, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Page
of 6